146 related articles for article (PubMed ID: 38611660)
21. Apocrine Metaplasia Found at MR Biopsy: Is There Something to be Learned?
Gao Y; Dialani V; DeBenedectis C; Johnson N; Brachtel E; Slanetz P
Breast J; 2017 Jul; 23(4):429-435. PubMed ID: 28079289
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Features in Probably Benign and Malignant Nonmass Enhancement in Breast MRI.
Ahmadinejad N; Azizinik F; Khosravi P; Torabi A; Mohajeri A; Arian A
Int J Breast Cancer; 2024; 2024():6661849. PubMed ID: 38523651
[TBL] [Abstract][Full Text] [Related]
23. Enhancement parameters on dynamic contrast enhanced breast MRI: do they correlate with prognostic factors and subtypes of breast cancers?
Kim JY; Kim SH; Kim YJ; Kang BJ; An YY; Lee AW; Song BJ; Park YS; Lee HB
Magn Reson Imaging; 2015 Jan; 33(1):72-80. PubMed ID: 25179138
[TBL] [Abstract][Full Text] [Related]
24. Utility and Diagnostic Performance of Automated Breast Ultrasound System in Evaluating Pure Non-Mass Enhancement on Breast Magnetic Resonance Imaging.
Kwon BR; Chang JM; Kim SY; Lee SH; Shin SU; Yi A; Cho N; Moon WK
Korean J Radiol; 2020 Nov; 21(11):1210-1219. PubMed ID: 32729267
[TBL] [Abstract][Full Text] [Related]
25. [Breast cancer subtypes based on ER/PR and Her2 expression: comparison of MR imaging features].
Hao L; Yu RS; Cui F; Ren XC; Xu HB; Xu KY
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(11):819-23. PubMed ID: 23859386
[TBL] [Abstract][Full Text] [Related]
26. Estrogen receptor and breast MR imaging features: a correlation study.
Chen JH; Baek HM; Nalcioglu O; Su MY
J Magn Reson Imaging; 2008 Apr; 27(4):825-33. PubMed ID: 18383260
[TBL] [Abstract][Full Text] [Related]
27. Revisiting Nonmass Enhancement in Breast MRI: Analysis of Outcomes and Follow-Up Using the Updated BI-RADS Atlas.
Chikarmane SA; Michaels AY; Giess CS
AJR Am J Roentgenol; 2017 Nov; 209(5):1178-1184. PubMed ID: 28834447
[TBL] [Abstract][Full Text] [Related]
28. Breast MR biopsy: Pathological and radiological correlation.
Dratwa C; Jalaguier-Coudray A; Thomassin-Piana J; Gonin J; Chopier J; Antoine M; Trop I; Darai E; Thomassin-Naggara I
Eur Radiol; 2016 Aug; 26(8):2510-9. PubMed ID: 26511630
[TBL] [Abstract][Full Text] [Related]
29. Correlation between high resolution dynamic MR features and prognostic factors in breast cancer.
Lee SH; Cho N; Kim SJ; Cha JH; Cho KS; Ko ES; Moon WK
Korean J Radiol; 2008; 9(1):10-8. PubMed ID: 18253071
[TBL] [Abstract][Full Text] [Related]
30. Patterns of malignant non-mass enhancement on 3-T breast MRI help predict invasiveness: using the BI-RADS lexicon fifth edition.
Lee SM; Nam KJ; Choo KS; Kim JY; Jeong DW; Kim HY; Kim JY
Acta Radiol; 2018 Nov; 59(11):1292-1299. PubMed ID: 29758996
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of MRI-Directed Breast Ultrasound and Lesion Characteristics Affecting Visualization on Breast Ultrasound.
Xiao L; Simmons C; Khanani S
Curr Probl Diagn Radiol; 2022; 51(5):717-721. PubMed ID: 35272882
[TBL] [Abstract][Full Text] [Related]
32. Significant MRI indicators of malignancy for breast non-mass enhancement.
Yang QX; Ji X; Feng LL; Zheng L; Zhou XQ; Wu Q; Chen X
J Xray Sci Technol; 2017; 25(6):1033-1044. PubMed ID: 29154312
[TBL] [Abstract][Full Text] [Related]
33. Morphology evaluation of nonmass enhancement on breast MRI: Effect of a three-step interpretation model for readers' performances and biopsy recommendations.
Shimauchi A; Ota H; Machida Y; Yoshida T; Satani N; Mori N; Takase K; Tozaki M
Eur J Radiol; 2016 Feb; 85(2):480-8. PubMed ID: 26781155
[TBL] [Abstract][Full Text] [Related]
34. Breast Dynamic Contrast Enhanced MRI: Fibrocystic Changes Presenting as a Non-mass Enhancement Mimicking Malignancy.
Milosevic ZC; Nadrljanski MM; Milovanovic ZM; Gusic NZ; Vucicevic SS; Radulovic OS
Radiol Oncol; 2017 Jun; 51(2):130-136. PubMed ID: 28740447
[TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of dynamic contrast enhancement and diffusion-weighted MRI for differentiation of benign from malignant non-mass enhancement breast lesions.
Zhang J; Li L; Zhang L; Zhe X; Tang M; Lei X; Zhang X
Front Oncol; 2024; 14():1332783. PubMed ID: 38544833
[TBL] [Abstract][Full Text] [Related]
36. Relationships Between Human-Extracted MRI Tumor Phenotypes of Breast Cancer and Clinical Prognostic Indicators Including Receptor Status and Molecular Subtype.
Net JM; Whitman GJ; Morris E; Brandt KR; Burnside ES; Giger ML; Ganott M; Sutton EJ; Zuley ML; Rao A
Curr Probl Diagn Radiol; 2019; 48(5):467-472. PubMed ID: 30270031
[TBL] [Abstract][Full Text] [Related]
37. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of breast cancer malignancy, prognostic factors and molecular subtypes using a continuous-time random-walk MR diffusion model.
Chang H; Wang D; Li Y; Xiang S; Yang YX; Kong P; Fang C; Ming L; Wang X; Zhang C; Jia W; Yan Q; Liu X; Zeng Q
Eur J Radiol; 2023 Sep; 166():111003. PubMed ID: 37506477
[TBL] [Abstract][Full Text] [Related]
39. Nonmass enhancement lesions of the breast on core needle biopsy: outcomes, frequency of malignancy, and pathologic findings.
Bartels AK; Fadare O; Hasteh F; Zare SY
Hum Pathol; 2021 May; 111():92-97. PubMed ID: 33722650
[TBL] [Abstract][Full Text] [Related]
40. Two Distinct Types of Linear Distribution in Nonmass Enhancement at Breast MR Imaging: Difference in Positive Predictive Value between Linear and Branching Patterns.
Machida Y; Tozaki M; Shimauchi A; Yoshida T
Radiology; 2015 Sep; 276(3):686-94. PubMed ID: 25875971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
